Results for tag: "Cerebrovascular Diseases Drug"

The Cerebrovascular Diseases Drug market is a subset of the Cardiovascular Drugs market, focusing on drugs used to treat cerebrovascular diseases. These drugs are used to treat conditions such as stroke, transient ischemic attack, and cerebral aneurysm. They are typically administered orally or intravenously, and may include anticoagulants, antiplatelet agents, thrombolytics, and vasodilators. The Cerebrovascular Diseases Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Bristol-Myers Squibb, and Novartis. Show Less Read more